BIOGEN INC. Retained Earnings 2008-2026 | BIIB
Beta
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is BIOGEN INC.'s current retained earnings?
BIOGEN INC. (BIIB) annual retained earnings for 2025 was $20.55B, a 6.71% increase from 2024. BIOGEN INC. retained earnings for the quarter ending March 31, 2026 was $20.87B.
What was BIOGEN INC.'s retained earnings in 2024?
BIOGEN INC. annual retained earnings for 2024 was $19.26B, a 9.26% increase from 2023.
What was BIOGEN INC.'s retained earnings in 2023?
BIOGEN INC. annual retained earnings for 2023 was $17.63B, a 7.05% increase from 2022.
What is BIOGEN INC.'s 5-year retained earnings CAGR?
BIOGEN INC. retained earnings grew at a compound annual growth rate (CAGR) of 8.02% from FY2020 to FY2025, going from $13.98B to $20.55B over 5 years.
Retained Earnings History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.0%
FY2020
$13.98B
→
FY2025
$20.55B
080910111213141516171819202122232425
5 years selected
Retained Earnings History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $20.55B | +6.7% | 10-K |
| FY2024 | $19.26B | +9.3% | 10-K |
| FY2023 | $17.63B | +7.1% | 10-K |
| FY2022 | $16.47B | +18.4% | 10-K |
| FY2021 | $13.91B | -0.5% | 10-K |
| FY2020 | $13.98B | -15.1% | 10-K |
| FY2019 | $16.46B | +1.2% | 10-K |
| FY2018 | $16.26B | +2.8% | 10-K |
| FY2017 | $15.81B | +4.9% | 10-K |
| FY2016 | $15.07B | +23.5% | 10-K |
| FY2015 | $12.21B | +31.5% | 10-K |
| FY2014 | $9.28B | +46.2% | 10-K |
| FY2013 | $6.35B | +41.5% | 10-K |
| FY2012 | $4.49B | +44.4% | 10-K |
| FY2011 | $3.11B | +65.9% | 10-K |
| FY2010 | $1.87B | +75.2% | 10-K |
| FY2009 | $1.07B | +295.6% | 10-K |
| FY2008 | $270.2M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →